Consun Pharmaceutical Group Ltd (1681.HK) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Consun Pharmaceutical Group Ltd gives H1 2014 net profit guidance


Tuesday, 5 Aug 2014 07:27am EDT 

Consun Pharmaceutical Group Ltd:Expects that it would record significant increase in net profit for H1 2014 as compared with that for H1 2013. 

Company Quote

3.96
-0.03 -0.75%
30 Jun 2016